Skip to main content

Benefits of Getting a #COVID-19 #Vaccine

COVID-19 vaccines are safe

  • COVID-19 vaccines were developed using science that has been around for decades.
  • COVID-19 vaccines are not experimental. They went through all the required stages of clinical trials. Extensive testing and monitoring have shown that these vaccines are safe and effective.
  • COVID-19 vaccines have received and continue to undergo the most intensive safety monitoring in U.S. history. 

COVID-19 vaccines are effective

  • COVID 19-vaccines are effective. They can keep you from getting and spreading the virus that causes COVID-19. Learn more about the different COVID-19 vaccines.
  • COVID-19 vaccines also help keep you from getting seriously ill even if you do get COVID-19.
  • Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.

Once you are fully vaccinated, you can start doing more

  • After you are fully vaccinated for COVID-19, you can resume many activities that you did before the pandemic. You can resume activities without wearing a mask or staying 6 feet apart, except where required by federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance.
  • People are not considered fully vaccinated until 2 weeks after their second dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine, or 2 weeks after a single-dose of Johnson & Johnson’s Janssen COVID-19 vaccine. You should keep using all the tools available to protect yourself and others until you are fully vaccinated.

COVID-19 vaccination is a safer way to help build protection

  • Get vaccinated regardless of whether you already had COVID-19. Studies have shown that vaccination provides a strong boost in protection in people who have recovered from COVID-19,.
  • Learn more about the clinical considerations for people were treated for COVID-19 with monoclonal antibodies or convalescent plasma, or history of multisystem inflammatory syndrome in adults or children (MIS-A or MIS-C).
  • COVID-19 is still a threat to people who are unvaccinated. Some people who get COVID-19 can become severely ill, which could result in hospitalization, and some people have ongoing health problems several weeks or even longer after getting infected. Even people who did not have symptoms when they were infected can have these ongoing health problems.

Immunity after COVID-19 vaccination

  • There is still a lot we are learning about COVID-19 vaccines and CDC is constantly reviewing evidence and updating guidance. We don’t know how long protection lasts for those who are vaccinated.
  • What we do know is that COVID-19 has caused very serious illness and death for a lot of people.
  • If you get COVID-19, you also risk giving it to loved ones who may get very sick. Getting a COVID-19 vaccine is a safer choice.
  • At this time, there are limited data on vaccine effectiveness in people who are immunocompromised, including those taking immunosuppressive medications. Learn more about the considerations for fully vaccinated people who are immunocompromised.

None of the COVID-19 vaccines can make you sick with COVID-19

None of the COVID-19 vaccines contain the live virus that causes COVID-19 so a COVID-19 vaccine cannot make you sick with COVID-19. 

Comments

Popular posts from this blog

#COVID-19 #Vaccines and #Vaccination

  Key Points Available evidence suggests the currently authorized mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) provide protection against a variety of strains, including B.1.1.7 (originally identified in the United Kingdom) and B.1.351 (originally identified in South Africa). Other vaccines show reduced efficacy against B.1.351 but may still protect against severe disease. Continued monitoring of vaccine effectiveness against variants is needed. A growing body of evidence indicates that people fully vaccinated with an mRNA vaccine (Pfizer-BioNTech and Moderna) are less likely to have asymptomatic infection or to transmit SARS-CoV-2 to others. Studies are underway to learn more about the benefits of Johnson & Johnson/Janssen vaccine. However, the risk for SARS-CoV-2 infection in fully vaccinated people cannot be completely eliminated as long as there is continued community transmission of the virus. At this time, there are limited data on vaccine effectiveness in people who

Frequently Asked Questions about #COVID-19 #Vaccination

If I have already had COVID-19 and recovered, do I still need to get vaccinated with a COVID-19 vaccine? Yes, you should be vaccinated regardless of whether you already had COVID-19. That’s because experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible—although rare—that you could be infected with the virus that causes COVID-19 again. Studies have shown that vaccination provides a strong boost in protection in people who have recovered from COVID-19. Learn more about why getting vaccinated is a safer way to build protection than getting infected. If you were treated for COVID-19 with monoclonal antibodies or convalescent plasma, you should wait 90 days before getting a COVID-19 vaccine. Talk to your doctor if you are unsure what treatments you received or if you have more questions about getting a COVID-19 vaccine. If you or your child has a history of multisystem inflam

COVID 19 - Delta and Delta Plus Variant

SARS-CoV-2 Delta variant, also known as lineage B.1.617.2, is a variant of lineage B.1.617 of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India in late 2020. The World Health Organization (WHO) named it the Delta variant on 31 May 2021. It has mutations in the gene encoding the SARS-CoV-2 spike protein causing the substitutions T478K, P681R and L452R, which are known to affect the transmissibility of the virus as well as whether it can be neutralised by antibodies for previously circulating variants of the COVID-19 virus. Public Health England (PHE) in May 2021 observed secondary attack rates to be 51–67% higher than the alpha variant. On 7 May 2021, PHE changed their classification of lineage B.1.617.2 from a variant under investigation (VUI) to a variant of concern (VOC) based on an assessment of transmissibility being at least equivalent to B.1.1.7 (Alpha variant); the UK's SAGE subsequently estimated a "realistic" possibility of being 50% mor